Loading candles…
Asarfi Hospital Ltd, incorporated in 2005 and headquartered in Dhanbad, Jharkhand, operates in the healthcare industry. The company provides a range of medical services including primary health services, super speciality health services, and tertiary care. Its service offerings encompass cardiology, neurosciences, oncology, general surgery, and a dedicated cancer hospital unit. In late 2024, it plans to operationalize a dedicated Cancer Hospital unit within its multispecialty healthcare facility. The company does not have publicly listed shares or noted subsidiaries.
This page is a live market overview for ASARFI HOSPITAL LIMITED (ASARFI) on the BSE. As a listed security, ASARFI HOSPITAL LIMITED is tracked in the Equities segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ASARFI before placing trades on tick2trade.
As of the latest feed, ASARFI last traded at ₹230.5 on BSE, down ₹3.5 (1.50%) from the previous close of ₹234. Today's session range is ₹230 – ₹234, against a 52-week band of ₹230 – ₹234. Traded volume today stands at 25.00K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ASARFI in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ASARFI is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ASARFI HOSPITAL LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ASARFI. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ASARFI option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.